These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Elevated chitin content reduces the susceptibility of Candida species to caspofungin. Walker LA; Gow NA; Munro CA Antimicrob Agents Chemother; 2013 Jan; 57(1):146-54. PubMed ID: 23089748 [TBL] [Abstract][Full Text] [Related]
5. Candida and candidaemia. Susceptibility and epidemiology. Arendrup MC Dan Med J; 2013 Nov; 60(11):B4698. PubMed ID: 24192246 [TBL] [Abstract][Full Text] [Related]
6. Hsp90 governs echinocandin resistance in the pathogenic yeast Candida albicans via calcineurin. Singh SD; Robbins N; Zaas AK; Schell WA; Perfect JR; Cowen LE PLoS Pathog; 2009 Jul; 5(7):e1000532. PubMed ID: 19649312 [TBL] [Abstract][Full Text] [Related]
8. Global analysis of the evolution and mechanism of echinocandin resistance in Candida glabrata. Singh-Babak SD; Babak T; Diezmann S; Hill JA; Xie JL; Chen YL; Poutanen SM; Rennie RP; Heitman J; Cowen LE PLoS Pathog; 2012; 8(5):e1002718. PubMed ID: 22615574 [TBL] [Abstract][Full Text] [Related]
9. Elevated cell wall chitin in Candida albicans confers echinocandin resistance in vivo. Lee KK; Maccallum DM; Jacobsen MD; Walker LA; Odds FC; Gow NA; Munro CA Antimicrob Agents Chemother; 2012 Jan; 56(1):208-17. PubMed ID: 21986821 [TBL] [Abstract][Full Text] [Related]
10. Genotypic, proteomic, and phenotypic approaches to decipher the response to caspofungin and calcineurin inhibitors in clinical isolates of echinocandin-resistant Candida glabrata. Ceballos-Garzon A; Monteoliva L; Gil C; Alvarez-Moreno C; Vega-Vela NE; Engelthaler DM; Bowers J; Le Pape P; Parra-Giraldo CM J Antimicrob Chemother; 2022 Feb; 77(3):585-597. PubMed ID: 34893830 [TBL] [Abstract][Full Text] [Related]
11. In vitro pharmacodynamics and in vivo efficacy of fluconazole, amphotericin B and caspofungin in a murine infection by Candida lusitaniae. Sandoval-Denis M; Pastor FJ; Capilla J; Sutton DA; Fothergill AW; Guarro J Int J Antimicrob Agents; 2014 Feb; 43(2):161-4. PubMed ID: 24360922 [TBL] [Abstract][Full Text] [Related]
13. PKC signaling regulates drug resistance of the fungal pathogen Candida albicans via circuitry comprised of Mkc1, calcineurin, and Hsp90. LaFayette SL; Collins C; Zaas AK; Schell WA; Betancourt-Quiroz M; Gunatilaka AA; Perfect JR; Cowen LE PLoS Pathog; 2010 Aug; 6(8):e1001069. PubMed ID: 20865172 [TBL] [Abstract][Full Text] [Related]
14. In vitro and in vivo effects of echinocandins against Candida parapsilosis sensu stricto, Candida orthopsilosis and Candida metapsilosis. Spreghini E; Orlando F; Tavanti A; Senesi S; Giannini D; Manso E; Barchiesi F J Antimicrob Chemother; 2012 Sep; 67(9):2195-202. PubMed ID: 22635526 [TBL] [Abstract][Full Text] [Related]
15. Paradoxical effect of caspofungin against Candida bloodstream isolates is mediated by multiple pathways but eliminated in human serum. Shields RK; Nguyen MH; Du C; Press E; Cheng S; Clancy CJ Antimicrob Agents Chemother; 2011 Jun; 55(6):2641-7. PubMed ID: 21422223 [TBL] [Abstract][Full Text] [Related]
16. Lipid Flippase Subunit Cdc50 Mediates Drug Resistance and Virulence in Cryptococcus neoformans. Huang W; Liao G; Baker GM; Wang Y; Lau R; Paderu P; Perlin DS; Xue C mBio; 2016 May; 7(3):. PubMed ID: 27165800 [TBL] [Abstract][Full Text] [Related]
17. Evaluation of aminocandin and caspofungin against Candida glabrata including isolates with reduced caspofungin susceptibility. Brzankalski GE; Najvar LK; Wiederhold NP; Bocanegra R; Fothergill AW; Rinaldi MG; Pattterson TF; Graybill JR J Antimicrob Chemother; 2008 Nov; 62(5):1094-100. PubMed ID: 18658194 [TBL] [Abstract][Full Text] [Related]
18. A Mechanosensitive Channel Governs Lipid Flippase-Mediated Echinocandin Resistance in Cryptococcus neoformans. Cao C; Wang Y; Husain S; Soteropoulos P; Xue C mBio; 2019 Dec; 10(6):. PubMed ID: 31822582 [TBL] [Abstract][Full Text] [Related]
19. CRZ1, a target of the calcineurin pathway in Candida albicans. Karababa M; Valentino E; Pardini G; Coste AT; Bille J; Sanglard D Mol Microbiol; 2006 Mar; 59(5):1429-51. PubMed ID: 16468987 [TBL] [Abstract][Full Text] [Related]
20. Dynamic, morphotype-specific Candida albicans beta-glucan exposure during infection and drug treatment. Wheeler RT; Kombe D; Agarwala SD; Fink GR PLoS Pathog; 2008 Dec; 4(12):e1000227. PubMed ID: 19057660 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]